Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

SR Ca(2+)-ATPase/phospholamban in cardiomyocyte function

M Tada1, T Toyofuku

  • 1Department of Medicine and Pathophysiology, Osaka University School of Medicine, Japan.

Journal of Cardiac Failure
|December 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endoscopic ultrasonography of superficial esophageal cancers using a thin ultrasound probe system equipped with switchable radial and linear scanning modes.

Gastrointestinal endoscopy·1996
Same author

Re-evaluation of myocardial FDG uptake in hyperglycemia.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·1996
Same author

Alpha 1-adrenergic stimulation induces cardiac tolerance to hypoxia via induction and activation of Mn-SOD.

The American journal of physiology·1996
Same author

Endoscopic papillary balloon dilation in cirrhotic patients: removal of common bile duct stones without sphincterotomy.

Endoscopy·1996
Same author

Phospholamban regulates the Ca2+-ATPase through intramembrane interactions.

The Journal of biological chemistry·1996
Same author

Modulation of the plasminogen activation system by inflammatory cytokines in human colon carcinoma cells.

British journal of cancer·1996
Same journal

Predictors and Outcomes of Heart Failure Diagnosis in the Community When Compared to Acute Care Settings: Insights from Linked Administrative Health Databases.

Journal of cardiac failure·2026
Same journal

Digitalis Today: From Doctrine to Disrepute to Disciplined Reconsideration.

Journal of cardiac failure·2026
Same journal

What Are HFpEF Mimics and What Are They Mimicking? Insights Into Our Conceptualization of Heart Failure With Preserved Ejection Fraction as a Disease.

Journal of cardiac failure·2026
Same journal

Right Ventricular Function and Echocardiographic Characteristics After Left Atrial to Coronary Sinus Shunting; Insights from ALT-FLOW Early Feasibility Study 3 Year Follow-Up.

Journal of cardiac failure·2026
Same journal

Greater Splanchnic Nerve Ablation Produces Echocardiographic Evidence of Reduced Left Ventricular Filling Pressures Across 12 Months of Follow-Up.

Journal of cardiac failure·2026
Same journal

JCF In Case You Missed It! Summary of American College of Cardiology (ACC) 2026.

Journal of cardiac failure·2026
See all related articles

Phospholamban inhibits cardiac calcium ATPase (SERCA 2) activity. Phosphorylation releases this inhibition, increasing calcium transport. Specific residues on SERCA 2 mediate this interaction.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Cardiology

Background:

  • Calcium ATPase (Ca ATPase) regulates intracellular calcium levels by pumping calcium into the sarcoplasmic and endoplasmic reticulum (SER).
  • Phospholamban is a phosphoprotein identified in cardiac myocytes that acts as an inhibitory co-factor for cardiac Ca ATPase (SERCA 2).

Purpose of the Study:

  • To identify the molecular interaction sites between phospholamban and SERCA 2.
  • To elucidate the mechanism by which phospholamban regulates SERCA 2 activity.

Main Methods:

  • Steady-state and pre-steady-state kinetic studies of Ca pump ATPase.
  • Protein kinase A (PKA) and CAM kinase-catalyzed phosphorylation.
  • Photoactivated cross-linking studies.
  • Site-directed mutagenesis.

Related Experiment Videos

  • In vitro expression systems.
  • Chimeric Ca ATPase construction (CH2).

    • Main Results:

    • Phosphorylation of phospholamban by PKA leads to its dissociation from SERCA 2, augmenting ATPase activity.
    • SERCA 1 and SERCA 2 exhibit similar Ca transport properties, both inhibited by phospholamban, unlike SERCA 3.
    • Six specific residues (Lys-Asp-Asp-Lys-Pro-Val402) in SERCA 2 were identified as crucial for phospholamban interaction.
    • The cytoplasmic region of phospholamban contains a binding site for SERCA 2.

    Conclusions:

    • The functional interaction between phospholamban and SERCA 2 occurs in the cytoplasmic region.
    • Specific residues on SERCA 2 are essential for mediating the inhibitory interaction with phospholamban.
    • Understanding these interactions is key to comprehending cardiac calcium handling and SERCA regulation.